Frontiers in Oncology (Jan 2024)

Predicting delayed remission in Cushing’s disease using radiomics models: a multi-center study

  • Wentai Zhang,
  • Wentai Zhang,
  • Dewei Zhang,
  • Shaocheng Liu,
  • He Wang,
  • Xiaohai Liu,
  • Congxin Dai,
  • Yi Fang,
  • Yanghua Fan,
  • Zhenqing Wei,
  • Ming Feng,
  • Renzhi Wang

DOI
https://doi.org/10.3389/fonc.2023.1218897
Journal volume & issue
Vol. 13

Abstract

Read online

PurposeNo multi-center radiomics models have been built to predict delayed remission (DR) after transsphenoidal surgery (TSS) in Cushing’s disease (CD). The present study aims to build clinical and radiomics models based on data from three centers to predict DR after TSS in CD.MethodsA total of 122 CD patients from Peking Union Medical College Hospital, Xuanwu Hospital, and Fuzhou General Hospital were enrolled between January 2000 and January 2019. The T1-weighted gadolinium-enhanced MRI images and clinical data were used as inputs to build clinical and radiomics models. The regions of interest (ROI) of MRI images were automatically defined by a deep learning algorithm developed by our team. The area under the curve (AUC) of receiver operating characteristic (ROC) curves was used to evaluate the performance of the models. In total, 10 machine learning algorithms were used to construct models.ResultsThe overall DR rate is 44.3% (54/122). According to multivariate Logistic regression analysis, patients with higher BMI and lower postoperative cortisol levels are more likely to achieve a higher rate of delayed remission. Among the 10 models, XGBoost achieved the best performance among all models in both clinical and radiomics models with AUC values of 0.767 and 0.819 respectively. The results from SHAP value and LIME algorithms revealed that postoperative cortisol level (PoC) and BMI were the most important features associated with DR.ConclusionRadiomics models can be built as an effective noninvasive method to predict DR and might be useful in assisting neurosurgeons in making therapeutic plans after TSS for CD patients. These results are preliminary and further validation in a larger patient sample is needed.

Keywords